Open access
Aug 2026
Regenerative perfusion bioreactor for biologics production with lower COGs.
Perfusion bioreactor systems enable intensified bioprocessing with high cell densities and volumetric productivities in monoclonal antibody (mAb) manufacturing. However, their widespread adoption remains constrained by the high consumption of chemically defined cell culture media. In this study, we introduce a multi-st...
Eric Wynne, D. Park, Hourieh Ahi et al.
· Biotechnology progress (Prin... · 0 citations